Show simple item record

Cimetidine is critical in CNS disorders

dc.contributor.authorShayanfar, A
dc.contributor.authorGharekhani, A
dc.contributor.authorGhasemian, E
dc.date.accessioned2018-08-26T08:38:55Z
dc.date.available2018-08-26T08:38:55Z
dc.date.issued2009
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/52975
dc.description.abstractThere are many CNS disorders with imbalance of dopamine in brain. Cimetidine adversely increases serum level of the prolactin and leads to activate feedback control to decrease prolactin release and intensifies synthesis and secretion of dopamine. Thus, cimetidine can be critical in CNS disorders. é 2009 Elsevier Ltd. All rights reserved.
dc.language.isoEnglish
dc.relation.ispartofBioscience Hypotheses
dc.subjectcimetidine
dc.subjectdopamine
dc.subjectprolactin
dc.subjectarticle
dc.subjectcentral nervous system disease
dc.subjectdopamine metabolism
dc.subjectdopamine release
dc.subjectfeedback system
dc.subjecthuman
dc.subjectprolactin blood level
dc.subjectprolactin release
dc.titleCimetidine is critical in CNS disorders
dc.typeArticle
dc.citation.volume2
dc.citation.issue3
dc.citation.spage180
dc.citation.epage181
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.1016/j.bihy.2009.01.003


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record